Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Galapagos ( (GLPG) ).
On February 10, 2026, Galapagos reported that Bank of America Corporation and its affiliates repeatedly crossed the 5% transparency threshold in the company’s voting rights in early February, triggering a series of regulatory notifications under Belgian disclosure rules. Between February 2 and February 5, 2026, Bank of America’s position in Galapagos’ shares and equivalent financial instruments rose as high as 7.23% of voting rights before being reduced to 5.04%, signaling active trading by a major financial institution but no change in Galapagos’ own capital structure.
The disclosure shows that on February 5, 2026, Bank of America and its affiliates held 132,087 direct voting rights and 3,191,854 equivalent financial instruments, together representing 5.04% of Galapagos’ 65,897,071 outstanding shares. For investors, the notifications highlight short-term shifts in derivative and equity exposure by a large banking group rather than a strategic stake-building move, providing transparency on ownership dynamics without indicating any direct operational impact on Galapagos.
The most recent analyst rating on (GLPG) stock is a Sell with a $22.00 price target. To see the full list of analyst forecasts on Galapagos stock, see the GLPG Stock Forecast page.
Spark’s Take on GLPG Stock
According to Spark, TipRanks’ AI Analyst, GLPG is a Neutral.
Galapagos’ overall stock score reflects a challenging financial and operational landscape. The company’s strong cash position and strategic partnerships are positive, but are overshadowed by significant operating losses, poor valuation metrics, and technical indicators suggesting potential downward pressure. Investors should be cautious and monitor the company’s ability to execute its strategic transformation and improve financial performance.
To see Spark’s full report on GLPG stock, click here.
More about Galapagos
Galapagos NV is a Belgium-based biotechnology company listed on Euronext and Nasdaq under the ticker GLPG. The company focuses on discovering, developing, and commercializing innovative medicines, with a portfolio that targets inflammatory, fibrotic, and other serious diseases across global markets.
Average Trading Volume: 110,114
Technical Sentiment Signal: Buy
Current Market Cap: $2.21B
See more data about GLPG stock on TipRanks’ Stock Analysis page.